These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7569759

  • 21. Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices.
    Verhaeghe J, Jaecques N, Rombouts J, Spaepen W, Cardon E, Lebrun F, Meurant JP.
    Scand J Gastroenterol Suppl; 1993; 195():25-34; discussion 34-5. PubMed ID: 8516655
    [Abstract] [Full Text] [Related]

  • 22. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
    Corinaldesi R, Stanghellini V, Raiti C, Rea E, Salgemini R, Barbara L.
    Gut; 1987 Mar; 28(3):300-5. PubMed ID: 3552906
    [Abstract] [Full Text] [Related]

  • 23. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F, Staub P, Hammer B, Guyot J, Miazza BM.
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [Abstract] [Full Text] [Related]

  • 24. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE, Long JF.
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [Abstract] [Full Text] [Related]

  • 25. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice.
    Dakkak M, Jones BP, Scott MG, Tooley PJ, Bennett JR.
    Br J Clin Pract; 1994 Mar; 48(1):10-4. PubMed ID: 8179973
    [Abstract] [Full Text] [Related]

  • 26. A German drug-monitoring study in general practice patients receiving cisapride for functional dyspepsia.
    Liehr H, Schmidt R.
    Scand J Gastroenterol Suppl; 1993 Mar; 195():54-8; discussion 58-9. PubMed ID: 8516660
    [Abstract] [Full Text] [Related]

  • 27. Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.
    Hveem K, Hausken T, Svebak S, Berstad A.
    Scand J Gastroenterol; 1996 May; 31(5):452-7. PubMed ID: 8734341
    [Abstract] [Full Text] [Related]

  • 28. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T, Barnert J, Dumitrascu DL, Fischer J, Wienbeck M.
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [Abstract] [Full Text] [Related]

  • 29. Factors affecting dose selection and outcome of cisapride treatment for dyspepsia in primary care. The Austro-Cis Study Group.
    Brunner H.
    Aliment Pharmacol Ther; 1996 Aug; 10(4):587-94. PubMed ID: 8853763
    [Abstract] [Full Text] [Related]

  • 30. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
    Holtmann G, Gschossmann J, Mayr P, Talley NJ.
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1641-8. PubMed ID: 12197843
    [Abstract] [Full Text] [Related]

  • 31. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
    Jian R, Ducrot F, Ruskone A, Chaussade S, Rambaud JC, Modigliani R, Rain JD, Bernier JJ.
    Dig Dis Sci; 1989 May; 34(5):657-64. PubMed ID: 2653742
    [Abstract] [Full Text] [Related]

  • 32. Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease--a comparative randomized double-blind trial.
    Arvanitakis C, Nikopoułos A, Theoharidis A, Giannoulis E, Vagios I, Anthopoulou H, Michailidis D, Tourkantonis A.
    Aliment Pharmacol Ther; 1993 Dec; 7(6):635-41. PubMed ID: 8161670
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dose-finding of cisapride in non-ulcer dyspepsia.
    Verlinden M.
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():31-5; discussion 72-3. PubMed ID: 2192504
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial.
    McDougall NI, Watson RG, Collins JS, McFarland RJ, Love AH.
    Aliment Pharmacol Ther; 1997 Jun; 11(3):487-95. PubMed ID: 9218071
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.